An HIV-prevention drug is widely available. Yet at-risk wome

In the U.S., women account for a fifth of new infections. But a persistent lack of education means few even know about the highly effective medication known as PrEP.

Related Keywords

Georgia , United States , Texas , Massachusetts , Atlanta , White House , District Of Columbia , Minnesota , South Africa , California , Uganda , San Francisco , Connecticut , Americans , Masonia Traylorspeaks , Jennifer Kates , Judithd Auerbach , Jewel Mullen , Robert Goldstein , Krista Martel , Joe Biden , Moupali Das , Haroldj Phillips , Rochelle Walensky , Dazon Dixon Diallo , Mitchell Warren , White House Office Of National , University Of California , Glaxosmithkline , Us Centers For Disease , Drug Administration , Melinda Gates Foundation , Kaiser Family Foundation , University Of Texas At Austin , National Geographic , Prevention Clinical Development Lead At Gilead Sciences , International Partnership For Microbicides , Dell Medical School , Affordable Care , Disease Control , Massachusetts General Hospital , New England , Gender Parity , Clinical Trials , Clinical Development Lead , Gilead Sciences , Well Project , Viiv Healthcare , International Partnership , President Joe Biden , White House Office , Affordable Care Act , Melinda Gates , Brit Williams , Economic Hardship Reporting ,